Direct Health Care Group, which is backed by ArchiMed, has acquired GATE Rehab Development AB, a Swedish maker of products focused on enabling patient mobility. No financial terms were disclosed.
ArchiMed’s Direct Health Care Group completes its first non-UK acquisition, buying Sweden’s GATE Rehab Development AB
This is Direct Health Care Group’s first buy-and-build transaction since its purchase by leading European private equity healthcare specialist, ArchiMed in December. More buy-and-build transactions for DHG – part of ArchiMed’s portfolio of partnering companies – in continental Europe will follow.
GATE Rehab Development AB, based in Reftele, Sweden, has extensive experience as a cutting-edge researcher, designer and manufacturer of technologically innovative products focused on enabling mobility.
Their Bure™ and EASY™ product ranges are well established within the Swedish healthcare market and beyond.
The strategic acquisition of GATE represents DHG’s first expansion into Continental Europe. It provides a launch pad for bringing DHG’s award-winning Intelligent Pressure Care Management systems to the Swedish and Nordic markets. DHG is a fully integrated developer and manufacturer of a range of innovative pressure care products designed to prevent medical issues such as pressure sores, which can lead to serious, sometimes life-threatening diseases.
Within the United Kingdom, DHG will now offer a range of sophisticated and clinically proven solutions from GATE, significantly expanding DHG’s current portfolio.
Graham Ewart, Direct Healthcare Group CEO, said:
“The acquisition of GATE represents our first strategic step in delivering our intelligent, market-leading pressure care management solutions into both the Swedish and wider European markets. With ArchiMed's financial muscle and global connections backing us, we intend to build a full range of products that address the serious issues associated with lack of mobility.”
The acquisition of GATE is the first in a series of strategic buy-and-build acquisitions that will focus on expanding DHG’s presence in Euope and elsewhere, whilst simultaneously adding clinically effective products that further the company’s philosopy of advancing movement and health.
Antoine Faguer, Archimed Partner, said: "We are very pleased to deliver our first acquisition less thanthree months after our initial investment to support DHG growth. We share a common vision with Graham Ewart and his team to build a pan-European player in this sector. Others acquisition opportunities are currently being studied to strengthen DHG’s global footprint.”
About ArchiMed – www.archimed-group.eu
ArchiMed is an independent investment firm specialized in the Healthcare industries. It is a strategic and financial partner to European and North American companies operating in the Biopharma, Medtech, Diagnostics, Life Sciences, Healthcare IT, Consumer Health, Public Safety and Care Services sectors.
ArchiMed’s international team combines investment, medical, technological and operational experience. It works alongside management teams to accelerate their business growth through internationalization, product and service range expansion and capacity extension, both organically and through acquisitions.
Over the last 20 years, ArchiMed’s leadership team directly managed and invested in over 40 small, medium and large-size healthcare companies throughout the world, with a combined value above five billion euros. ArchiMed’s investment capacity currently exceeds one billion euros and is potentially twice this amount when including its strategic investment partners.
About Direct Healthcare Group – www.directhealthcaregroup.com
No-one better understands the importance of movement and its relationship to both physical and mental health than Direct Healthcare Group, especially when the need to move directly affects the quality of daily living. DHG develops, manufactures and continuously refines a complete range of medical devices focused on early mobilization of patients in order to prevent health challenges associated with non-movement. The use of Direct Healthcare Group’s products and services means serious medical issues associated with reduced patient movement are anticipated, managed, and resolved. DHG is committed to better health outcomes, accelerated recovery and easier daily living.
About GATE Rehab Development AB – www.gaterd.com
GATE is a Swedish rehabilitation aids company with a long tradition of product research and development.
GATE develops and sells high quality products focused on enabling patient mobility in Sweden and across the world, including stand tall walkers, rollators, transfer platforms and hygiene chairs; all with innovative designs and novel solutions. GATE’s head office, manufacturing, and service centre is located in Reftele, within the Province of Småland, Sweden.